EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semi-synthetic products based on 7-hydroxymitragynine: a public health emergency

Franco Posa, Camilla Trussardi, Matteo Posa, Victoria Colmenares Pulido, Vanessa Vener

Medical Research Archives · 30.06.2026 · 14 (6)

DOI: 10.18103/mra.2026.0332 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 30.06.2026. Verfasst von Franco Posa und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last twenty-four months, the market for substances derived from Mitragyna speciosa (Kratom) has undergone a qualitative shift: alongside traditional leaf and crude extracts, semi-synthetic concentrated products based on 7-hydroxymitragynine (7-OH) have emerged, obtained through controlled oxidation of mitragynine and formulated as sublingual tablets, gummies, vaping devices, nasal sprays and edibles. These products, which can reach 98% 7-OH content as a single active ingredient, fall outside the botanical pharmacopoeia of kratom and de facto constitute a new class of semi-synthetic u-opioid agonists with potency comparable to, or exceeding, that of morphine. This position paper summarises the available pharmacological, neurobiological, toxicological and medico-legal evidence, with specific reference to the Italian legal context, and sets out operational recommendations for forensic pathologists, forensic toxicologists, medico-legal experts and technical consultants called upon to intervene in cases of suspected intoxication, death, occupational accident or criminal offence linked to the use of such products. The paper addresses: (a) the methodological problem of using mitragynine as a surrogate marker of kratom exposure in the presence of 7-OH-enriched products; (b) the post-mortem instability of 7-OH and its interpretive implications for causality assessment; (c) the evaluation of criminal responsibility (capacity to understand and to will) in chronic users; (d) the need to update the analytical panels of Italian toxicology laboratories.

Zitieren

APA

Posa, F., Trussardi, C., Posa, M., Pulido, V. C., & Vener, V. (2026). Semi-synthetic products based on 7-hydroxymitragynine: a public health emergency. Medical Research Archives, 14(6). https://doi.org/10.18103/mra.2026.0332

Vancouver

Posa F, Trussardi C, Posa M, Pulido VC, Vener V. Semi-synthetic products based on 7-hydroxymitragynine: a public health emergency. Medical Research Archives. 2026;14(6). doi:10.18103/mra.2026.0332

BibTeX
@article{Posa2026,
  author = {Posa, Franco and Trussardi, Camilla and Posa, Matteo and Pulido, Victoria Colmenares and Vener, Vanessa},
  title = {Semi-synthetic products based on 7-hydroxymitragynine: a public health emergency},
  journal = {Medical Research Archives},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.18103/mra.2026.0332}
}
Kostenlos starten →